John K. Jenkins's Insider Trades & SAST Disclosures

John K. Jenkins's most recent trade in Corbus Pharmaceuticals Holdings Inc was a trade of 16,000 Stock options (right to buy) done . Disclosure was reported to the exchange on May 30, 2025.

Share

Note

This is a custom search result for pattern John K. Jenkins.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Corbus Pharmaceuticals Hol...	John K. Jenkins	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 May 2025	16,000	16,000	-		-	Stock options (right to buy)
Corbus Pharmaceuticals Hol...	John K. Jenkins	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 May 2025	4,800	4,833 (0%)	0%		0	Common Stock, par value $0.0001 per share
Corbus Pharmaceuticals Hol...	John K. Jenkins	Director	Sale of securities on an exchange or to another person at price $ 7.35 per share.	30 May 2025	2,783	33 (0%)	0%	7.4	20,465	Common Stock, par value $0.0001 per share
Corbus Pharmaceuticals Hol...	John K. Jenkins	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 May 2024	2,783	2,816 (0%)	0%		0	Common Stock, par value $0.0001 per share
Corbus Pharmaceuticals Hol...	John K. Jenkins	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 May 2024	2,783	2,783	-		-	Stock Option (right to buy)
Corbus Pharmaceuticals Hol...	John K. Jenkins	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 May 2023	5,300	5,300	-		-	Stock Option (right to buy)
Corbus Pharmaceuticals Hol...	John K. Jenkins	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 May 2022	79,600	79,600	-		-	Stock Option(right to buy)
Corbus Pharmaceuticals Hol...	John K. Jenkins	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jun 2021	58,200	58,200	-		-	Stock Option (right to buy)
Corbus Pharmaceuticals Hol...	John K. Jenkins	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jun 2021	58,200	58,200	-		-	Stock Option (right to buy)

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades